课题基金 / 基金详情

THE FUNCTION OF RECQ HELICASE GENE FAMILY IN DNA RECOMBINATION AND JOINING

THE FUNCTION OF RECQ HELICASE GENE FAMILY IN DNA RECOMBINATION AND JOINING
RECQ解旋酶基因家族在DNA重组和连接中的功能
批准号:
10216204
负责人:
KONDO Naomi
金额:
$23.04万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2002

项目摘要

项目成果

KONDO Naomi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bloom syndrome and ataxia-telangiectasia are autosomal recessive human disorders characterized by immunodeficiency, genome instability and predisposition to develop cancer. Recent data reveal that the products of these two genes, BLM and ATM, interact and function together in recognizing abnormal DNA structures. To investigate the function of these two molecules in DNA damage, recognition, we generated double knockouts of ATM-/-BLM-/-In the DT40 chicken B-lymphocyte cell line. The double mutant cells were viable and exhibited a variety of characteristics of both ATM-/-and BLM-/-cells. There was no evidence for exacerbation of either phenotypes ; however, the more extreme radiosensitivity seen in ATM-/-and elevated sister chromatid exchange seen in BLM-/-cells were retained in the double mutants. These results suggest that ATM and BLM have largely distinct roles in recognizing different forms of damage in DNA, but also compatible with partially overlapping functions in recognizing breaks in radiation-damaged DNA.In addition, we showed that the combinational analysis of immunoblotting and immunohistochemistry is a useful approach to screening of BS.
期刊论文(70)
专著(0)
科研奖励(0)
会议论文
Kondo, N., Matsui, E., et al.: "Reduced interferon-gamma production and mutations of the interleukin-12 receptor beta(2) chain gene in atopic subjects"Int Arch Allergy Immunol. 124. 117-120 (2001)
Kondo, N.、Matsui, E. 等人:“特应性受试者中干扰素 γ 产生减少和白细胞介素 12 受体 β(2) 链基因突变”Int Arch Allergy Immunol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
近藤直実: "IgEクラススイッチ"メデイカルレビュー社. 271 (2001)
近藤直美:“IgE Class Switch” Medical Review Co., Ltd. 271 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sukegawa K,Kondo N, et al.: "Biochemical and structural analysis of missense mutation in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes."Hum Mol Genet. 9. 1283-1290 (2000)
Sukekawa K、Kondo N 等人:“引起粘多糖贮积症 IVA 表型的 N-乙酰半乳糖胺-6-硫酸酯硫酸酯酶错义突变的生化和结构分析。”Hum Mol Genet。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Beamish, H., Kondo, N.et al.: "Functional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasia mutated protein, ATM."J Blol Chem. 277. 30515-30523 (2002)
Beamish, H., Kondo, N.等人:“布卢姆综合征中 BLM 缺陷与共济失调毛细血管扩张突变蛋白 ATM 之间的功能联系。”J Blol Chem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
51
    Personalized prediction and prevention of allergic diseases
    • 批准号:
      15K11744
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2015
    • 负责人:
      KONDO Naomi
    • 依托单位:
    Molecular genetics and proteomics for gene-environmental relationship in allergy
    • 批准号:
      21591358
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      KONDO Naomi
    • 依托单位:
    Structure biology for the causative genes of atopy and order-made therapy in the environment.
    • 批准号:
      13470163
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2001
    • 负责人:
      KONDO Naomi
    • 依托单位:
    The causative genes for allergy and clinical use.
    • 批准号:
      10557075
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $8.45万
    • 财政年份:
      1998
    • 负责人:
      KONDO Naomi
    • 依托单位:
    国内基金
    海外基金
    牛磺胆酸通过靶向抑制BLM乳酸化修饰调控DNA同源重组修复逆转蒽环类化疗耐药的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李心远
    • 依托单位:
    BLM解旋酶抑制剂纳米马达智能给药系统构建及对前列腺癌的协同治疗作用
    • 批准号:
      82360558
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      32万元
    • 批准年份:
      2023
    • 负责人:
      陈琨
    • 依托单位:
    BLM DNA解旋酶作为抑制三阴性乳腺癌多倍体巨瘤细胞增殖和耐药作用靶点的分子调控机制研究
    • 批准号:
      --
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      33万元
    • 批准年份:
      2022
    • 负责人:
      刘杰麟
    • 依托单位:
    新型重组减毒沙门菌介导沉默BLM基因抗胃癌作用的研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2021
    • 负责人:
      王新友
    • 依托单位: